Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung biopsy in diffuse parenchymal lung disease.

I N Glaspole1, A U Wells, R M du Bois

  • 1Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|October 23, 2001
PubMed
Summary

Surgical lung biopsy offers the highest diagnostic sensitivity for diffuse parenchymal lung disease, achieving 90-95% accuracy. While newer imaging like high-resolution computed tomography (HRCT) improves diagnosis for some conditions, surgical biopsy remains crucial for others.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis.

European radiology·2017
Same author

Reply.

Arthritis & rheumatology (Hoboken, N.J.)·2016
Same author

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Arthritis & rheumatology (Hoboken, N.J.)·2015
Same author

Advances in radionuclide imaging of cardiac sarcoidosis.

British medical bulletin·2015
Same author

Approaches to the treatment of some of the troublesome manifestations of sarcoidosis.

Journal of internal medicine·2014
Same author

Endpoints for clinical trials of sarcoidosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2013

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Diagnostic Imaging

Background:

  • Diffuse parenchymal lung diseases (DPLDs) present diagnostic challenges.
  • Accurate diagnosis is crucial for prognosis and treatment planning.
  • Current diagnostic modalities include imaging and invasive procedures.

Purpose of the Study:

  • To define the role of surgical biopsy in diagnosing and determining the prognosis of DPLDs.
  • To evaluate the advantages and disadvantages of different biopsy procedures.
  • To guide the interpretation of biopsy results within a clinical context.

Main Methods:

  • Review of existing literature on surgical lung biopsy techniques (open lung biopsy, video-assisted thoracoscopic surgery).
  • Comparison of diagnostic sensitivity with high-resolution computed tomography (HRCT) and transbronchial biopsy.

Related Experiment Videos

  • Analysis of diagnostic accuracy for specific DPLDs based on current evidence.

    • Main Results:

    • Surgical lung biopsy demonstrates the highest diagnostic sensitivity (90-95%) for DPLDs.
    • HRCT and transbronchial biopsy achieve approximately 70% diagnostic rates.
    • HRCT aids in diagnosing conditions like cryptogenic fibrosing alveolitis, Langerhans' cell histiocytosis, lymphangioleiomyomatosis, and silicosis.
    • Vasculitides and other idiopathic interstitial pneumonias necessitate surgical biopsy.

    Conclusions:

    • Surgical lung biopsy remains the gold standard for diagnosing many DPLDs due to its high sensitivity.
    • While HRCT is increasingly valuable, it has limitations and cannot replace surgical biopsy for all conditions.
    • The decision to perform a surgical biopsy should consider diagnostic uncertainty and the specific disease entity.